Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
migrated information: read-across based on grouping of substances (category approach)
Adequacy of study:
key study
Study period:
Not applicable
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study well documented, meets generally accepted scientific principles, acceptable for assessment
Justification for data waiving:
other:
Cross-referenceopen allclose all
Reason / purpose for cross-reference:
reference to same study
Reason / purpose for cross-reference:
reference to other study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1989

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
The potential of the test material to induce respiratory adverse effects/damage to the lungs in Porton Wistar rats was investigated using intra-tracheal instillation of the test material as a single dose. Oedema resulting from the treatment was assessed by increases in lung wet weight together with elevation in the levels of a purified alveolar surface protein fraction derived from the perfused lungs. The formation of a protein rich oedematous fluid is a common early response to toxic substances.
The toxicity of the test material can be correlated with pulmonary oedema inducing capacity, since protein rich oedematous fluid is a common early response to toxic substances.
Assessment of oedematous reaction is carried out by determination of increased in lung wet weight together with elevated levels of a purified alveolar surface protein fraction derived from lungs which had been totally perfused of blood.
GLP compliance:
not specified
Test type:
other: Biochemical and pathological study in lungs
Limit test:
no

Test material

Constituent 1
Reference substance name:
Zinc chloride
EC Number:
231-592-0
EC Name:
Zinc chloride
Cas Number:
7646-85-7
IUPAC Name:
zinc dichloride
Details on test material:
- Name of test material (as cited in study report): Zinc chloride

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
- Weight at study initiation: 150 -200 g
- Diet (e.g. ad libitum): Commercial diet
- Water (e.g. ad libitum): Tap water

Administration / exposure

Route of administration:
other: Intratracheal
Type of inhalation exposure:
other: Intratracheal
Vehicle:
other: water
Details on inhalation exposure:
Not applicable
Analytical verification of test atmosphere concentrations:
not specified
Concentrations:
1. Investigation of rat lung response at different dose levels: 0.25, 0.5, 1.0, 2.0, 4.0 and 5.0 mg/kg bw
2. Investigation dose levels which produce early alveolar oedema: 0.25, 0.5, 1.0 or 1.5 mg/kg bw
3. Investigation of the effects of the perfusion procedure: 1.5 mg/kg bw
4. Investigation of the time course of oedema and any signs of fibrogenesis: 2.5 mg/kg bw
5. Histopatholgical examination of lungs: 2.5 mg/kg bw

No. of animals per sex per dose:
1. Investigation of lung response at low dose: 4
2. Investigation of rat lung response at different dose levels: Not reported
3. Investigation of dose level which produces early alveolar oedema: 6
4. Investigation of the effects of the perfusion procedure: 10
5. Investigation of the time course of oedema and any signs of fibrogenesis: 6
6. Histopatholgical examination of lungs: 10
Control animals:
yes
Details on study design:
- Duration of observation period following administration:
1. To investigate lung response at low dose: 2 and 4 wk
2. To investigate rat lung response at different dose levels: 12 h and 7 d
3. To investigate dose level which produces early alveolar oedema: 20 h
4. To investigate the effects of the perfusion procedure: 20 h
5. To investigate the time course of oedema and any signs of fibrogenesis: 6, 18, 28, 48, 72 h, 7 d and 14 d
6. Histopatholgical examination of lungs: 6, 28, 72 h, 7 d and 14 d

- Necropsy of survivors performed: yes

EXAMINATION
- Examination performed for different groups:
1. To investigate lung response at low dose: Lung wet weight and alveolar surface protein levels
2. To investigate rat lung response at different dose levels: Histopathological examination
3. To investigate dose level which produces early alveolar oedema: Concentration of protein in the lavage fluid
4. To investigate the effects of the perfusion procedure: Lung wet weight and alveolar surface protein levels
5. To investigate the time course of oedema and any signs of fibrogenesis: Lung wet weight, alveolar surface protein levels after all time intervals (6, 18, 28, 48, 72 h, 7 dand 14 d) and lung dried weight and hydroxyproline in the total lavaged lung after 7 and 14 d
6. Histopatholgical examination of lungs
- Other examinations: Biochemical analysis using standard techniques
Statistics:
Statistical analysis of the data was carried out using an unpaired Student's t-test and differences between mean values were considered significant when P < 0.05.

Results and discussion

Preliminary study:
Not applicable
Effect levelsopen allclose all
Sex:
male
Dose descriptor:
other: Elevated alveolar surface protein and lung wet weight
Effect level:
0.3 other: mg/kg bw
Exp. duration:
14 d
Sex:
male
Dose descriptor:
other: intra-alveolar oedema with charecteristic eosinophilic fluid accumulation and fibrin clots
Effect level:
> 0.5 other: mg/kg bw
Exp. duration:
12 h
Sex:
male
Dose descriptor:
other: interstitial fibrosis
Effect level:
2.5 other: mg/kg bw
Exp. duration:
14 d
Sex:
male
Dose descriptor:
other: Fibrogenic response
Effect level:
2.5 other: mg/kg bw
Exp. duration:
7 d
Mortality:
Not reported
Clinical signs:
other: Not observed
Body weight:
Not observed
Gross pathology:
Not observed
Other findings:
- Other observations:
1. Results for investigation of lung response at low dose after 2 or 4 wks: See Table 1
2. Results for investigation of rat lung response at different dose levels:
- Histologic (intra-alveolar oedema) evaluation after 12 h of instillation: Very slight, moderate and severe distribution of intra-alveolar oedema was observed at 1, 4 and 5 mg/kg bw respectively. Interstitial oedema was observed.
3. Results for investigation of dose level which produces early alveolar oedema and alveolar surface protein, after 20 h of instillation:
- Lung wet weight: Slight increase was observed, except for 0.25 mg/kg bw (not significant)
- Alveolar suface protein: Dose dependent increase, ranging from 5-50 mg, was observed
- Others: Upto 1.5 mg/kg bw, no visible signs of lung haemorrhage and red blood cells were observed in the lavage
4. Results for investigation of effects of perfusion procedure after 20 h: No significant changes in lung weight or in the alveolar surface protein were observed for perfused and non-perfused rat lungs
5. Results for investigation of time course of oedema and any signs of fibrogenesis: See Table 2
6. Results of histopatholgical examination of lungs at 6, 28, 72 h, 7 d and 14 d post-instillation: Interstitial fibrosis was observed in all the lungs after 14 d post-instillation



Any other information on results incl. tables

Table 1: Results for investigation of lung response at low dose (0.3 mg/kg bw) after 2 or 4 wks:

Time after

Instillation (weeks)

Treatment

 

n

 

Lung wet wt (g) as mean ± SD 

Alveolar surface protein (mg/rat) as mean ± SD

2

Distilled water

4

1.27 ± 0.08

3.5 ± 1.4

Zinc chloride

4

1.27 ± 0.04

4.6 ± 3.9

4

Distilled water

4

1.47 ± 0.15

4.3 ± 1.4

Zinc chloride

4

1.72 ± 0.32

34.4 ± 50.5

n = No. of animals

* = Significantly different from controls by Student's t-test for unpaired samples

Table 2: Results for effect of 2.5 mg/kg bw zinc chloride on lung oedema and alveolar surface protein at different time intervals and lavaged lung dry weights, and hydroxyproline levels (indicator of fibrogenesis) after 7 and 14 d post-exposure

Treatment

Time after instillation

n

Lung wet weight (g) as mean ± SD

Alveolar surface protein (mg) as 

mean ± SD

Dry lung weight (g) as 

mean ± SD 

Hydroxyproline (mg/lung) as mean ± SD

Control

6 h

6

1.29 ± 0.38

5.41 ± 2.43

-

-

Zinc chloride

6 h

6

1.97 ± 0.74

51.17 ± 40.09*

-

-

Zinc chloride

18 h

6

1.95 ± 0.34

30.09 ± 13.28

-

-

Control

28 h

4

1.10 ± 0.17

5.59 ± 2.46

-

-

Zinc chloride

28 h

6

2.80 ± 0.71*

71.97 ± 14.88*

-

-

Zinc chloride

2 d

5

2.21± 0.66

37.76 ± 25.85

-

-

Control

3 d

4

1.09 ± 0.04

3.25 ± 0.28

-

-

Zinc chloride

3 d

6

2.43 ± 0.64*

36.91± 1.76*

-

-

Control

7 d

4

1.13 ± 0.08

5.18 ± 2.08

0.188 ± 0.010

2.12 ± 0.26

Zinc chloride

7 d

6

2.05 ± 0.47*

9.99 ± 4.02

0.222 ± 0.023*

3.59 ± 0.88*

Control

14 d

5

1.17 ± 0.12

4.16 ± 0.69

0.166 ± 0.069

1.80 ± 0.25

Zinc chloride

14 d

6

1.57 ± 0.42

13.77 ± 7.83*

0.202 ± 0.069

3.46 ± 1.56

n = No. of animals

* = Significantly different from controls by Student's t-test for unpaired samples

Applicant's summary and conclusion

Interpretation of results:
sligthly toxic
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Significant lung damage, in terms of oedematous reaction, was induced in rats on single intra-tracheal instillation of zinc chloride
Executive summary:

A number of single intra-tracheal instillation studies were performed in Wistar rats to investigate the delayed respiratory adverse-effects, and the potential of zinc chloride to damage the lungs.

 

In the study for investigation of pulmonary effects at low dose (0.3 mg/kg bw), a delayed elevated alveolar surface protein, with accompanying increased lung wet weight were observed after 4 wks. These effects correlated histologically with the quantitative biochemical assay for alveolar surface protein in a lavage fluid fraction.

Histopathological studies confirmed the induction intra-alveolar oedema at 12 h post-instillation of different dose levels (0.25-5 mg/kg bw) and interstitial fibrosis in the lungs at 2.5 mg/kg bw, after 14 d. The oedematous reaction in individual animals, after 20 h at 0.25-1.5 mg/kg bw, were variable, but the overall effect was dose dependent.  

 

The onset of oedema, was rapid with maximal effects being noted within 3 days when high doses (2.5 mg/kg bw) of test material were instilled. However, in majority of the animals the severe oedematous reaction regressed between 3 and 7 d. In some animals, adjudged by histochemistry and elevated lung hydroxyproline, evidence of a fibrogenic response was observed 7 d post-exposure.

 

Hence, significant lung damage, in terms of oedematous reaction was induced in rats, on single intra-tracheal instillation of zinc chloride.